HT-29 cells
Human HT-29 cells were isolated from the colon of a patient with colon adenocarcinoma.
Tumour growth in vivo
The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of SCID-CB17 mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.
The mice bearing HT-29 tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or subcutaneous injection of the compounds. Per os administration is also possible
Figure 1: (View PDF)
Tumour growth curve of the HT-29 cells as xenograft Mean ± SEM (n=3; take rate 100%)
Antineo can also perform an intra-caecal implantation.